Top

Netherlands Heart Journal

Published in:

Open Access 01-01-2016 | Original Article

“Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience

Authors: I.A.H. ter Horst, Y. Kuijpers, J. van ’t Sant, A.E. Tuinenburg, M.J. Cramer, M. Meine

Published in: Netherlands Heart Journal | Issue 1/2016

Abstract

Objective

The objective of the study was to examine whether cardiac resynchronisation therapy upgrade procedures are more complex and associated with more complications than de novo implantations.

Method

We retrospectively compared 134 upgrade procedures performed between 2006–2012 with a random, equally sized, sample of de novo CRT device implantations in the same period. Procedural data and the occurrence of periprocedural (≤ 30 days) and long-term device-related (≤ 1 year) complications were analysed. Complications with consequences were defined as those in need of adjustment of standard care.

Results

Median time to upgrade was 57 (31–115) months. There were no significant differences in procedure duration, radiation time or total hospitalisation between upgrades and de novo implantations. Perioperative complications occurred in 6.7 % of upgrade patients and in 9.0 % of de novo patients. The most frequently seen complications were phrenic nerve stimulation, coronary sinus dissection and pocket haematoma. Procedure success was comparable (upgrade: 98.5 % versus de novo: 96.3 %). A total of 236 patients completed 1 year of follow-up. Ten (4.2 %) patients had a long-term device-related complication with consequences including phrenic nerve stimulation, lead dislodgement/dysfunction, and infection (upgrade: 3.5 % versus de novo: 4.9 %).

Conclusion

Upgrade procedures are not more complex nor associated with more complications than de novo CRT implantations.

Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of Cardiac Resynchronisation Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronisation Therapy (MADIT-CRT). Circulation. 2011;123:1061–72.PubMedCrossRef

Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronisation therapy: meta-analysis of randomized controlled trials. Am Heart J. 2012;163:260–7; e263.PubMedPubMedCentralCrossRef

Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy The Task Force on cardiac pacing and resynchronisation therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281–329.PubMedCrossRef

Bogale N, Witte K, Priori S, et al. The European Cardiac Resynchronisation Therapy Survey: comparison of outcomes between de novo cardiac resynchronisation therapy implantations and upgrades. Eur J Heart Fail. 2011;13:974–83.PubMedCrossRef

Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553–61.PubMedCrossRef

Nery PB, Fernandes R, Nair GM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010;21:786–90.PubMed

Tang ASL, Wells GA, Talajic M, et al. Cardiac-Resynchronisation Therapy for Mild-to-Moderate Heart Failure. N Engl J Med 2010;363:2385–95.PubMedCrossRef

Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35:1186–94.PubMedPubMedCentralCrossRef

Scott PA, Whittaker A, Mehmood ZEB, et al. Rates of upgrade of ICD recipients to CRT in clinical practice and the potential impact of the more liberal use of CRT at initial implant. Pacing Clin Electrophysiol. 2012;35:73–80.PubMedCrossRef

10.

Ghani A, Delnoy PP, Ramdat Misier AR, et al. Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation. Neth Heart J. 2014;22:286–91. doi: 10.1007/s12471-014-0556-6.PubMedPubMedCentralCrossRef

11.

Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronisation therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011;154:401–12.PubMedCrossRef

Title: “Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience
Authors: I.A.H. ter Horst
Y. Kuijpers
J. van ’t Sant
A.E. Tuinenburg
M.J. Cramer
M. Meine
Publication date: 01-01-2016
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 1/2016
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-015-0771-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

“Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience

Abstract

Objective

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Echocardiography and cardiac resynchronisation therapy, friends or foes?

To implant or not to implant?

Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping

Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays

Cardiac dyssynchrony and response to cardiac resynchronisation therapy in heart failure: can genetic predisposition play a role?

Getting the LV lead to the right spot